Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out drugs are emerging.

Good afternoon, everyone, and welcome to the Stryve Foods Third Quarter Fiscal 2024 Financial Results Conference Call. [Operator Instructions] This call is being recorded on Wednesday, November 13, ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply lower Friday, after President-elect Donald Trump named Robert F. Kennedy Jr.

GLP-1RA drugs and SGLT2 inhibitors were associated with a lower risk for nonalcoholic fatty liver disease among individuals with type 2 diabetes.

A new study supports the notion that the same mechanisms that help folks lose weight with Ozempic and its kin also work to ...

GLP-1RA prescription trends, real-world effectiveness, and predictors for access and rationing were highlighted at ...

We narrow down the most important market and consumer trends that could influence dairy product innovation in 2025.

A registered dietitian reveals nine food that work like weight-loss drugs, helping to curb cravings and suppress your ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

A new British study adds to growing evidence that GLP-1 diabetes meds might help curb problem drinking. Two clinical trials ...

GLP-1 medications, like Ozempic and Wegovy, mimic natural hormones in the body that regulate blood sugar and insulin levels. They’re used to treat type 2 diabetes and obesity. These drugs curb the ...